Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.

Mila Donker, Saskia Litière, Gustavo Werutsky, Jean Pierre Julien, Ian S. Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez, Emiel J T Rutgers, Nina Bijker

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences